Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary Sjögren's syndrome: new clinical and therapeutic concepts.

Literature DB >> 15498797

Primary Sjögren's syndrome: new clinical and therapeutic concepts.

Abstract

Sicca features are the central clinical manifestations of Sjögren's syndrome (SS), but recent studies have confirmed that primary SS has a systemic expression, including extraglandular manifestations. Patients with a predominantly extraepithelial expression should be managed differently from patients with predominantly periepithelial or sicca limited disease. In coming years treatment will be based on muscarinic agonists for sicca features and immunosuppressive/biological agents for extraglandular features.

Entities: Disease Species

Mesh：

Substances：

Year: 2004 PMID： 15498797 PMCID： PMC1755414 DOI： 10.1136/ard.2004.025676

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

112 in total

1. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992.

Authors: P B Martens; S R Pillemer; L T Jacobsson; W M O'Fallon; E L Matteson
Journal: J Rheumatol Date: 1999-06 Impact factor: 4.666

2. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.

Authors: T Coates; J P Slavotinek; M Rischmueller; D Schultz; C Anderson; M Dellamelva; M R Sage; T P Gordon
Journal: J Rheumatol Date: 1999-06 Impact factor: 4.666

3. Intravenous gammaglobulin in the treatment of central nervous system vasculitis associated with Sjögren's syndrome.

Authors: H Canhão; J E Fonseca; A Rosa
Journal: J Rheumatol Date: 2000-04 Impact factor: 4.666

4. Myocarditis and primary Sjögren's syndrome.

Authors: K Yoshioka; H Tegoshi; T Yoshida; N Uoshima; Y Kasamatsu
Journal: Lancet Date: 1999-12-04 Impact factor: 79.321

5. Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjögren's syndrome.

Authors: S Miyawaki; S Nishiyama; K Matoba
Journal: Intern Med Date: 1999-12 Impact factor: 1.271

6. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.

Authors: F N Skopouli; U Dafni; J P Ioannidis; H M Moutsopoulos
Journal: Semin Arthritis Rheum Date: 2000-04 Impact factor: 5.532

7. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both).

Authors: M Pertovaara; M Korpela; H Uusitalo; J Pukander; A Miettinen; H Helin; A Pasternack
Journal: Ann Rheum Dis Date: 1999-07 Impact factor: 19.103

8. Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers.

Authors: M Tishler; I Yaron; I Shirazi; M Yaron
Journal: Ann Rheum Dis Date: 1999-04 Impact factor: 19.103

9. The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients.

Authors: M Pertovaara; M Korpela; T Kouri; A Pasternack
Journal: Rheumatology (Oxford) Date: 1999-11 Impact factor: 7.580

Review 10. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.

Authors: S Nusair; A Rubinow
Journal: Semin Arthritis Rheum Date: 1999-06 Impact factor: 5.532

70 in total

Review 1. Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors: B M Lodde; B J Baum; P P Tak; G Illei
Journal: Ann Rheum Dis Date: 2006-07-31 Impact factor: 19.103

2. Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice.

Authors: S-T Ju; W N Jarjour; R Sharma; L Zheng; X Guo; S M Fu
Journal: J Autoimmun Date: 2007-01-03 Impact factor: 7.094

10. X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome.

Authors: Margherita Sisto; Loredana Lorusso; Sabrina Lisi
Journal: Clin Exp Med Date: 2015-12-11 Impact factor: 3.984

Primary Sjögren's syndrome: new clinical and therapeutic concepts.

1. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992.

2. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.

3. Intravenous gammaglobulin in the treatment of central nervous system vasculitis associated with Sjögren's syndrome.

4. Myocarditis and primary Sjögren's syndrome.

5. Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjögren's syndrome.

6. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.

7. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both).

8. Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers.

9. The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients.

Review 10. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.

Review 1. Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

2. Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice.

3. Can an ordinary neurological examination induce a dissection of the vertebral artery?: a case report.

4. Tuberculosis infection in primary Sjögren's syndrome: a nationwide population-based study.

5. Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome.

Review 6. The microbiome in autoimmune diseases.

7. Treating Sjögren's Syndrome: Insights for the Clinician.

8. Transcultural adaptation of the EULAR activity index for primary Sjogren's syndrome in Argentine.

Review 9. Lessons from diseases mimicking Sjögren's syndrome.

10. X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome.